News

January 6, 2017February 23, 2017

SELLAS to Present Corporate and Clinical Updates at Upcoming Conference

News

SELLAS Life Sciences will present corporate and clinical updates on its novel cancer immunotherapies at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, Jan 9-13. According to a press release, Angelos Stergiou, ... Read more

January 5, 2017January 5, 2017

Lung Biopsy Essential to Correct Diagnosis of Asbestos-Related Cancers, Case Study Says

News

Occupational cancer should be considered in all cases of workplace asbestos exposure according to a case study published in the Romanian Journal of Morphology and Embryology. Moreover, an accurate assessment ... Read more

January 4, 2017

Study Lauds Imaging Method’s Sensitivity in Assessing MPM Patients’ Response to Chemotherapy

News

Different imaging techniques can have different sensitivity in evaluating the response of malignant pleural mesothelioma (MPM) patients to chemotherapy, but a new study found a technique called 18F-FDG-PET/CT to be superior to others, and it ... Read more

January 3, 2017

Gene Variations May Help Predict Survival in Mesothelioma Patients Receiving Platinum-based Chemotherapy, Study Finds

News

Variations in the immune-system-related FAS ligand (FASL) gene may help predict how long a malignant pleural mesothelioma patient who received platinum-based chemotherapy can survive without the disease progressing. A study in Egypt showed ... Read more

December 22, 2016

Intrapleural Gene Therapy Slows Tumor Growth in Mice with Malignant Mesothelioma

News

The endothelial cell protein C receptor (EPCR) suppresses tumor growth in malignant pleural mesothelioma (MPM) by rendering cells more susceptible to cell death-activating mechanisms, according to a study published in Scientific ... Read more

December 21, 2016

Phone Consulting Helped Veterans Get Rapid Mesothelioma Treatment, Study Shows

News

A national telephone consulting service helped U.S. military veterans who believed they had mesothelioma gain timely access to experts in Boston who could treat them as well as any mesothelioma ... Read more

December 20, 2016

Pleural Biopsy More Accurate for Diagnosing Malignant Mesothelioma, Study Finds

News

A pleural biopsy is a more accurate and efficient method of diagnosing malignant diseases that cause fluid leakage in the lungs than pleural effusion cell block (a cell preparation using ... Read more

December 19, 2016December 20, 2016

Mesothelioma Tumor Cells Can Generate Their Own Vasculature, Study Finds

News

Vasculogenic mimicry, a process in which tumor cells can form structures that resemble blood vessels and that can serve as blood conduits, is a common feature in malignant mesothelioma, according ... Read more

December 16, 2016December 20, 2016

Combo Treatment, Including Lung-Sparing Surgery, Helps Mesothelioma Patients Live Years Longer

News

A combination of lung-sparing surgery, chemotherapy, and using light to kill malignant cells helped patients with malignant pleural mesothelioma live years longer than those who received chemotherapy only, according to ... Read more

December 15, 2016December 15, 2016

FDA Grants Nintedanib Orphan Drug Status to Treat Mesothelioma

News

The US Food and Drug Administration (FDA) has granted orphan-drug status to nintedanib as a treatment for the asbestos-related cancer mesothelioma. “Nintedanib, our triple angiokinase inhibitor, has shown promise as ... Read more